Related Experiment Video
Updated: Sep 21, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies
Hirokazu Nagai1, Yinghua Li, Sonoko Hatano
11st Department of Internal Medicine, Nagoya University School of Medicine, Showa-ku, Nagoya, Japan. nagaih@nnh.hosp.go.jp
Abstract:
The homeobox gene PROX1 is related to the Drosophila prospero gene, which is expressed in the developing central nervous system and lens-secreting cone cells. We found that the PROX1 gene had missense and nonsense mutations in 4 of 29 hematologic cell lines analyzed. Decreased mRNA expression was also observed in half of these cell lines by RT-PCR. The restoration of PROX1 gene expression after treatment with the demethylating agent 5-aza-2'-deoxycytidine, as well as bisulfite sequencing analysis, indicated that gene silencing is caused by DNA hypermethylation at intron 1. Such hypermethylation was also seen in primary lymphomas (56.3%, 18/32) in a tumor-specific manner. These findings indicate that the profile of the PROX1 gene corresponds to that of a candidate tumor-suppressor gene.
Insights
The PROX1 gene, linked to development, shows mutations and silencing in blood cancers due to DNA hypermethylation. This suggests PROX1 acts as a tumor suppressor, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- The homeobox gene PROX1 is evolutionarily conserved, with roles in the developing central nervous system and lens.
- Dysregulation of homeobox genes is implicated in various cancers.
Purpose of the Study:
- To investigate the role of the PROX1 gene in hematologic malignancies.
- To determine the mechanisms of PROX1 gene silencing in cancer cells.
Main Methods:
- Analysis of PROX1 gene mutations and mRNA expression in hematologic cell lines using sequencing and RT-PCR.
- Treatment of cell lines with a demethylating agent (5-aza-2'-deoxycytidine) to assess gene expression restoration.
- Bisulfite sequencing to analyze DNA methylation status at the PROX1 gene locus.
- Examination of PROX1 methylation in primary lymphoma samples.
Main Results:
- Missense and nonsense mutations in PROX1 were identified in 4 out of 29 hematologic cell lines.
- Reduced PROX1 mRNA expression was observed in approximately 50% of analyzed cell lines.
- PROX1 gene expression was restored upon treatment with 5-aza-2'-deoxycytidine, indicating epigenetic regulation.
- DNA hypermethylation, specifically at intron 1 of PROX1, was identified as the mechanism for gene silencing.
- Tumor-specific hypermethylation of PROX1 was found in 56.3% of primary lymphoma samples.
Conclusions:
- The PROX1 gene exhibits characteristics of a tumor suppressor gene in hematologic malignancies.
- DNA hypermethylation-induced silencing of PROX1 is a significant event in lymphomagenesis.
- PROX1 alterations represent a potential biomarker and therapeutic target in blood cancers.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Lineage Commitment
Differentiation of Common Myeloid Progenitor Cells

